Literature DB >> 13274056

Evidence that serotonin has a role in brain function.

B B BRODIE, A PLETSCHER, P A SHORE.   

Abstract

Entities:  

Keywords:  BRAIN/metabolism; RAUWOLFIA ALKALOIDS/effects; SEROTONIN/metabolism

Mesh:

Substances:

Year:  1955        PMID: 13274056     DOI: 10.1126/science.122.3177.968

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  41 in total

1.  [Mechanism of action of reserpine].

Authors:  E MUSCHOLL
Journal:  Klin Wochenschr       Date:  1959-03-01

2.  Interaction of the effects of tyramine, amphetamine and reserprine in man.

Authors:  M G GELDER; J R VANE
Journal:  Psychopharmacologia       Date:  1962-10-05

3.  Formation and catabolism of histamine in brain tissue in vitro.

Authors:  T WHITE
Journal:  J Physiol       Date:  1959-12       Impact factor: 5.182

4.  The influence of thenalidine on reserpine- and serotonin-induced gastric ulcers in rats.

Authors:  B NIKODIJEVIC; S VANOV
Journal:  Experientia       Date:  1960-10-15

5.  Reserpine-a comparison of chronic toxicity in animals with clinical toxicity.

Authors:  J M PARKER; C W MURPHY
Journal:  Can Med Assoc J       Date:  1961-05-27       Impact factor: 8.262

6.  The action of 5-hydroxytryptamine, 5-hydroxytryptophan and reserpine on intestinal peristalsis in anaesthetized guinea-pigs.

Authors:  E BULBRING; A CREMA
Journal:  J Physiol       Date:  1959-04-23       Impact factor: 5.182

7.  Behavioral effects of 5-hydroxytryptophan.

Authors:  M H APRISON; C B FERSTER
Journal:  Experientia       Date:  1960-04-15

8.  Influence of iproniazid pretreatment on formation of gastric ulcers by reserpine in the rat.

Authors:  I LEUSEN; E LACROIX; G DEMEESTER
Journal:  Experientia       Date:  1959-02-15

9.  Increase of free 5-hydroxytryptamine in blood plasma by reserpine and a benzoquinolizine derivative.

Authors:  M K PAASONEN; A PLETSCHER
Journal:  Experientia       Date:  1959-12-15

10.  A clinical and biochemical study of a trial of iproniazid in the treatment of depression.

Authors:  C M PARE; M SANDLER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1959-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.